tm
Seeing Is Believing
tm
Seeing Is Believing
ELVN is currently covered by 2 analysts with an average price target of $63.75. This is a potential upside of $18.14 (4.49%) from yesterday's end of day stock price of $61.01.
Enliven Therapeutics's activity chart (see below) currently has 27 price targets and 25 ratings on display. The stock rating distribution of ELVN is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 90.58% with an average time for these price targets to be met of 430.64 days.
Highest price target for ELVN is $73, Lowest price target is $56, average price target is $63.75.
Most recent stock forecast was given by SALIM SYED from MIZUHO on 18-Aug-2026. First documented stock forecast 29-Mar-2023.
Currently out of the existing stock ratings of ELVN, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 09-Apr-2024
$73
$13.18 (22.03%)
$62
Buy Since 09-Sep-2024
$64
$4.18 (6.99%)
$56
Buy Since 13-Dec-2024
$45
$-5.08 (-10.14%)
$45
Buy Since 11-Jun-2024
$52
$1.92 (3.83%)
$40
Buy Since 31-Oct-2024
$27
$-23.08 (-46.09%)
What is ELVN (Enliven Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ELVN (Enliven Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ELVN (Enliven Therapeutics)?
Which analyst is the currently most bullish on ELVN (Enliven Therapeutics)?
Which analyst is the currently most reserved on ELVN (Enliven Therapeutics)?
